Deleterious mutations do not necessarily lead to the incidence of inhibitors in hemophilia A patients receiving replacement therapy. Maternal chimeric cells migrated into a fetus with hemophilia A during pregnancy could induce tolerance toward FVIII.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218421 | PMC |
| http://dx.doi.org/10.1182/bloodadvances.2020001832 | DOI Listing |
Publication Analysis
Top Keywords
hemophilia patients
8
maternal microchimerism
4
microchimerism protects
4
protects hemophilia
4
patients inhibitor
4
inhibitor development
4
development deleterious
4
deleterious mutations
4
mutations lead
4
lead incidence
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!